NFKB1 and Alzheimer disease: Owing to the activity of the NF-kB pathway, Hericium erinaceus administration also reduced iNOS expression (Figure 5C) and TNF-α (Figure 5D) and IL6 (Figure 5E) levels, which were increased in the AD group.